Highlights Cytokinetics, Incorporated

Equities

CYTK

US23282W6057

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
59.53 ^USD	-0.65%		-4.14%	-28.70%

May. 17	Cytokinetics, Incorporated Announces Resignation of Sandford D. Smith as Board of Directors	CI
May. 15	Transcript : Cytokinetics, Incorporated - Shareholder/Analyst Call

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cytokinetics Q1 Net Loss Narrows, Revenue Declines	May. 08	MT
Earnings Flash (CYTK) CYTOKINETICS INCORPORATED Posts Q1 Revenue $835,000, vs. Street Est of $0.9M	May. 08	MT
Cytokinetics, Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 08	CI
Cytokinetics, Incorporated Announces Topline Data from Phase 1 Clinical Study of Ck-4021586	May. 08	CI
Cytokinetics, Incorporated Announces CEDAR-HCM Is Open to Enrollment	May. 08	CI
Sector Update: Health Care Stocks Rise Friday Afternoon	Apr. 05	MT
Cytokinetics Reports Positive Follow-On Data for Prospective Heart Medication; Shares Rise	Apr. 05	MT
Cytokinetics Presents Additional 48-Week Data from Forest-Hcm, the Open Label Extension Clinical Study of Aficamten, At the American College of Cardiology 73rd Annual Scientific Session	Apr. 05	CI
Cytokinetics Q4 Net Loss Narrows, Revenue Decreases; 2024 Outlook Issued	Feb. 27	MT
Earnings Flash (CYTK) CYTOKINETICS INCORPORATED Reports Q4 Revenue $1.7M, vs. Street Est of $13.3M	Feb. 27	MT
Cytokinetics, Incorporated Provides Revenue Guidance for 2024	Feb. 27	CI
Cytokinetics, Incorporated Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27	CI
Cytokinetics, Incorporated Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 27	CI
Novartis Interest in Cytokinetics Takeover Has Cooled	Jan. 11	MT
Correction: Market Chatter: Novartis Interest in Cytokinetics Takeover Has Cooled	Jan. 11	MT
Cytokinetics Shares Slide as Novartis Reportedly Shies Away From Deal	Jan. 11	DJ
Novartis drops pursuit of Cytokinetics - WSJ	Jan. 11	RE
Novartis Pursuit of Cytokinetics Reportedly Cools	Jan. 10	CI
Cytokinetics Shares Jump 16% After WSJ Report of Novartis Deal	Jan. 08	DJ
Novartis Reportedly in Advanced Talks to Buy Cytokinetics, Deal Possible This Week	Jan. 08	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Cytokinetics, Incorporated

Equities

CYTK

US23282W6057

Highlights

Filters